Nephrology

Measuring cystatin C levels is more accurate than creatinine testing in predicting serious complications of kidney disease.

Overlapping clinical definitions of the causes and characteristics of intradialytic hypertension make it a frustrating condition to diagnose and treat

AASK trial data show mutation in MYH9 gene significantly increases risk of ESRD in African Americans with kidney disease related to hypertension.

Prominent cardiologist has some blunt advice for clinicians who are trying to apply JNC 7 guidelines in patients with CKD.

CKD stage is a predictor of incident AF and mortality risk in elderly patients. Patients with CKD also frequently exhibit major EKG abnormalities.

SHARP trial shows that combination statin therapy in patients with CKD reduces risk of heart attack and stroke without raising cancer risk.

By targeting a novel inflammatory pathway, bardoxolone methyl can reduce the stage of chronic kidney disease and improve estimated glomerular filtration rate.

Researchers continue to study the cardiovascular benefits associated with the DASH diet. Patients with CKD should adjust potassium intake.

Patients with chronic kidney disease treated by a nephrologist earlier in the care process face decreased risk of end-stage renal disease and death.

Study showing racial differences in rate of kidney function decline may point to new opportunities for kidney disease prevention.

Evidence-based strategies can alleviate gaps in providers' knowledge of chronic kidney disease and diabetes in underserved patient populations.

Type 2 diabetics with silent cerebral infarction are more than twice as likely to develop or die from end-stage kidney disease.

Research shows that early-stage CKD is related to atherosclerosis; therefore, management of CKD might lower the incidence of coronary spastic angina

Dr. Rasheed Balogun discusses the risk factors and rising worldwide incidence rates of chronic kidney disease.